why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: July 12, 2025

Clinical Trial: Intravitreal Faricimab in Patients With Refractory Macular Edema

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Age-Related Macular Degeneration

Study Type: INTERVENTIONAL


Official Title: The Effect of Intravitreal Faricimab in Patients With Refractory Macular Edema and Refractory Age Related Macular Degeneration

Brief Summary: This prospective study will include about 40 patients with resistant wet age-related macular degeneration (AMD), diabetic macular edema (DME), or retinal vein occlusion edema (RVO) edema.The inclusion criteria are that all patients must be 40 years old or older, diagnosed with active wet AMD or macular edema due to RVO or DME, and have received at least four previous monthly injections of anti-VEGF other than faricimab.All patients will be switched to receive four loading doses of intravitreal faricimab (6 mg) at…

Read more